Neuropsychological correlates of P50 sensory gating in patients with schizophrenia

Schizophrenia Research

Volumn 143, Issue 1, 2013, Pages 102-106

  Sánchez Morla, Eva María ^a,b,d   Santos, José Luis ^a   Aparicio, Ana ^a   García Jiménez, María Ángeles ^a   Soria, Carmen ^a   Arango, Celso ^c  

^a HOSPITAL VIRGEN DE LA LUZ   (Spain)

^b HOSPITAL UNIVERSITARIO DE GUADALAJARA   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^d UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

Cognition; Evoked potential recordings; Neuropsychological measures; P50; Schizophrenia

Indexed keywords

ADULT; ARTICLE; COGNITION; CONTROLLED STUDY; CORRELATION ANALYSIS; EVOKED RESPONSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL FUNCTION; MENTAL PERFORMANCE; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; SCHIZOPHRENIA; SENSORY GATING;

ACOUSTIC STIMULATION; ADULT; COGNITION DISORDERS; ELECTROENCEPHALOGRAPHY; ELECTROOCULOGRAPHY; EVOKED POTENTIALS, AUDITORY; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; REACTION TIME; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SENSORY GATING;

EID: 84871931296     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2012.10.017     Document Type: Article

References (55)

1. Adler L.E., Pachtman E., Franks R.D., Pecevich M., Waldo M.C., Freedman R. Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia. Biol. Psychiatry 1982, 17:639-654.
2. Adler L.E., Waldo M.C., Tatcher A., Cawthra E., Baker N., Freedman R. Lack of relationship of auditory gating defects to negative symptoms in schizophrenia. Schizophr. Res. 1990, 3:131-138.
3. Adler L.E., Olincy A., Cawthra A.M., McRae K.A., Harris J.G., Nagamoto H.T., Waldo M.C., Hall M., Bowles A., Woodward L., Ross R.G., Freedman R. Varied effects of atypical neuroleptics on P50 auditory gating in schizophrenia patients. Am. J. Psychiatry 2004, 161:1822-1828.
4. Arango C., Summerfelt A., Buchanan R.W. Olanzapine effects on auditory sensory gating in schizophrenia. Am. J. Psychiatry 2003, 160:2066-2068.
5. Becker J., Gomes I., Ghisolfi E.S., Schuch A., Ramos F.L.P., Ehlers J.A., Nora D.B., Lara D.R., Da Costa J.C. Clozapine, but not typical antipsychotics, correct P50 suppression deficit in patients with schizophrenia. Clin. Neurophysiol. 2004, 115:396-401.
6. Beninger R.J., Baker T.W., Florczynski M.M., Banasikowski T.J. Regional differences in the action of antipsychotic drugs: implications for cognitive effects in schizophrenic patients. Neurotox. Res. 2010, 18:229-243.
7. Boutros N.N., Korzyukov O., Jansen B., Feingold A., Bell M. Sensory gating deficits during the mid-latency phase of information processing in medicated schizophrenia patients. Psychiatry Res. 2004, 126:203-215.
8. Boutros N.N., Brockhaus-Dumke A., Gjini K., Vedeniapin A., Elfakhani M., Burroughs S., Keshavan M. Sensory-gating deficit of the N100 mid-latency auditory evoked potential in medicated schizophrenia patients. Schizophr. Res. 2009, 113(2-3):339-346.
9. Bozikas V.P., Andreou C. Longitudinal studies of cognition in first episode psychosis: a systematic review of the literature. Aust. N. Z. J. Psychiatry 2011, 45:93-108.
10. Braff D.L., Geyer M.A. Sensorimotor gating and schizophrenia: human and animal model studies. Arch. Gen. Psychiatry 1990, 47:181-188.
11. Bramon E., Rabe-Hesketh S., Sham P., Murray R.M., Frangou S. Meta-analysis of the P300 and P50 waveforms in schizophrenia. Schizophr. Res. 2004, 70:315-329.
12. Brenner C.A., Kieffaber P.D., Clementz B.A., Johannesen J.K., Shekar A., O'Donnell B.F., Hetrick W.P. Event-related potential abnormalities in schizophrenia: a failure to "gate in" salient information?. Schizophr. Res. 2009, 113(2-3):332-338.
13. Brockhaus-Dumke A., Mueller R., Faigle U., Klosterkoetter J. Sensory gating revisited: relation between brain oscillations and auditory evoked potentials in schizophrenia. Schizophr. Res. 2008, 99:239-249.
14. Brockhaus-Dumke A., Schultze-Lutter F., Mueller R., Tendolkar I., Bechdolf A., Pukrop R., Klosterkoetter J., Ruhrmann S. Sensory gating in schizophrenia: P50 and N100 gating in antipsychotic-free subjects at risk, first-episode, and chronic patients. Biol. Psychiatry 2008, 64(5):376-384.
15. Chang W., Arfken C.L., Sangal M.P., Boutros N.N. Probing the relative contribution of the first and second responses to sensory gating indices: a meta-analysis. Psychophysiology 2011, 48:980-992.
16. Cullum C.M., Harris J.G., Waldo M.C. Neurophysiological and neuropsychological evidence for attentional dysfunction in schizophrenia. Schizophr. Res. 1993, 10:131-141.
17. Dalecki A., Croft R.J., Johnstone S.J. An evaluation of P50 paired-click methodologies. Psychophysiology 2012, 48:1692-1700.
18. De Wilde O.M., Bour L.J., Dingemans P.M., Koelman J.H.T.M., Linszen D.H. A meta-analysis of P50 studies in patients with schizophrenia and relatives: differences in methodology between research groups. Schizophr. Res. 2007, 97:137-151.
19. Erwin R.J., Turetsky B.I., Moberg P., Gur R.C., Gur R.E. P50 abnormalities in schizophrenia: relationship to clinical and neuropsychological indices of attention. Schizophr. Res. 1998, 33:157-167.
20. Fuerst D.R., Gallinat J., Boutros N.N. Range of sensory gating values and test-retest reliability in normal subjects. Psychophysiology 2007, 44(4):620-626.
21. Heaton R.K., Miller S.W., Taylor M.J., Grant I. Revised comprehensive norms for an expanded Halstead-Reitan Battery: demographically adjusted neuropsychological norms for African American and Caucasian adults 2004, Psychological Assessment Resources, Inc., Lutz, FL.
22. Heinrichs R.W., Zakzanis K.K. Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 1998, 12(3):426-445.
23. Hong L.E., Summerfelt A., Mitchell B.D., McMahon R.P., Wonodi I., Buchanan R., Thaker G.K. Sensory gating endophenotype based on its neural oscillatory pattern and heritability estimate. Arch. Gen. Psychiatry 2008, 65(9):1008-1016.
24. Hong X., Chan R.C., Zhuang X., Jiang T., Wan X., Wang J., Xiao B., Zhou H., Jiang L., Weng B. Neuroleptic effects on P50 sensory gating in patients with first-episode never-medicated schizophrenia. Schizophr. Res. 2009, 108(1-3):151-157.
25. Hong L.E., Summerfelt A., Mitchell B.D., O'Donnell P., Thaker G.K. A shared low-frequency oscillatory rhythm abnormality in resting and sensory gating in schizophrenia. Clin. Neurophysiol. 2012, 123:285-292.
26. Hsieh M.H., Liu K., Liu S., Chiu M., Hwu H., Chen A.C.N. Memory impairment and auditory evoked potential gating deficit in schizophrenia. Psychiatry Res. Neuroimaging 2004, 130:161-169.
27. Jin Y., Bunney W.E., Sandman C.A., Patterson J.V., Fleming K., Moenter J.R., Kalali A.H., Hetrick W.P., Potkin S.G. Is P50 suppression a measure of sensory gating in schizophrenia?. Biol. Psychiatry 1998, 47:463-467.
28. Kurtz M.M. Neurocognitive impairment across the lifespan in schizophrenia: an update. Schizophr. Res. 2005, 74:15-26.
29. Lewandowski K.E., Cohen B.M., Ongur D. Evolution of neuropsychological dysfunction during the course of schizophrenia and bipolar disorder. Psychol. Med. 2011, 41(2):225-241.
30. Lijffijt M., Lane S.D., Meier S.L., Boutros N.N., Burroughs S., Steinberg J.L., Moeller F.G., Swann A.C. P50, N100, and P200 sensory gating: relationships with behavioural inhibition, attention, and working memory. Psychophysiology 2009, 46(5):1059.
31. Louchart De La Chapelle S., Levillain D., Ménard J.F., Van Der Elst A., Allio G., Haouzir S., Dollfus S., Campion D., Thibaut F. P50 inhibitory gating deficit is correlated with the negative symptomatology of schizophrenia. Psychiatry Res. 2005, 136:27-34.
32. Mathiak K., Ackermann H., Rapp A., Mathiak K.A., Shergill S., Riecker A., Kircher T.T.J. Neuromagnetic oscillations and hemodynamic correlates of P50 suppression in schizophrenia. Psychiatry Res. Neuroimaging 2011, 194:95-104.
33. Mazhari S., Price G., Waters F., Dragovic M., Jablensky A. Evidence of abnormalities in mild-latency auditory evoked responses (MLAER) in cognitive subtypes of patients with schizophrenia. Psychiatry Res. 2011, 187:317-323.
34. Myles-Worsley M., Ord L., Blailes F., Ngiralmau H., Freedman R. P50 sensory gating in adolescents from a pacific island isolate with elevated risk for schizophrenia. Biol. Psychiatry 2004, 55:663-667.
35. Nagamoto H.T., Adler L.E., Waldo M.C., Freedman R. Sensory gating in schizophrenics and normal controls: effects of changing stimulation interval. Biol. Psychiatry 1989, 25:549-561.
36. Nagamoto H.T., Adler L.E., McRae K.A., Huettl P., Cawthra E., Gerhardt G., Hea R., Griffith J. Auditory P50 in schizophrenics on clozapine: improved gating parallels clinical improvement and changes in plasma 3-methoxy-4 hydroxyphenylglycol. Neuropsychobiology 1999, 39:10-17.
37. Nuechterlein K.H., Green M.F., Kern R.S., Baade L.E., Barch D.M., Cohen J.D., Essock S., Fenton W.S., Frese F.J., Gold J.M., Goldberg T., Heaton R.K., Keefe R.S., Kraemer H., Mesholam-Gately R., Seidman L.J., Stover E., Weinberger D.R., Young A.S., Zalcman S., Marder S.R. The MATRICS consensus cognitive battery, part 1: test selection, reliability, and validity. Am. J. Psychiatry 2008, 165(2):203-213.
38. Olincy A., Braff D.L., Adler L.E., Cadenhead K.S., Calkins M.E., Dobie D.J., Green M.F., Greenwood T.A., Gur R.E., Gur R.C., Light G.A., Mintz J., Nuechterlein K., Radant A.D., Schork N.J., Seidman L.J., Siever L.J., Silverman J.M., Stone W.S., Swerdlow N.R., Tsuang D.W., Tsuang M.T., Turetsky B.I., Wagner B.D., Freedman R. Inhibition of the P50 cerebral evoked response to repeated auditory stimuli: results from the Consortium on Genetics of Schizophrenia. Schizophr. Res. 2010, 119:175-182.
39. Patterson J.V., Hetrick W.P., Boutros N.N., Jin Y., Sandman C., Stern H., Potkin S., Bunney W.E. P50 sensory gating ratios in schizophrenics and controls: a review and data analysis. Psychiatry Res. 2008, 158:226-247.
40. Potter D., Summerfelt A., Gold J., Buchanan R.W. Review of clinical correlates of P50 sensory gating abnormalities in patients with schizophrenia. Schizophr. Bull. 2006, 32:692-700.
41. Reichenberg A. The assessment of neuropsychological functioning in schizophrenia. J. Clin. Exp. Neuropsychol. Dialogues Clin. Neurosci. 2010, 12(3):383-392.
42. Sánchez-Morla E.M., García-Jiménez M.A., Barabash A., Martínez-Vizcaíno V., Mena J., Cabranes-Díaz J.A., Baca-Baldomero E., Santos J.L. P50 sensory gating deficit is a common marker of vulnerability to bipolar disorder and schizophrenia. Acta Psychiatr. Scand. 2008, 1-6.
43. Sánchez-Morla E.M., Barabash A., Martínez-Vizcaíno V., Tabarés-Seisdedos R., Balanza-Martínez V., Cabranes-Díaz J.A., Baca-Baldomero E., Santos Gómez J.L. Comparative study of neurocognitive function in euthymic bipolar patients and stabilized schizophrenic patients. Psychiatry Res. 2009, 169:220-228.
44. Sánchez-Morla E.M., Santos J.L., Aparicio A., García-Jiménez M.A., Villanueva C., Martínez-Vizcaíno V., Arango C. Antipsychotics effects on auditory sensory gating in schizophrenia patients. Eur. Neuropsychopharmacol. 2009, 19:905-909.
45. Santos J.L., Sánchez-Morla E.M., Aparicio A., García-Jiménez M.A., Villanueva C., Martínez-Vizcaíno V., Arango C. P50 gating in deficit and nondeficit schizophrenia. Schizophr. Res. 2010, 119:183-190.
46. Schretlen D.J., Cascella N.G., Meyer S.M., Kingery L.R., Testa S.M., Munro C.A., Pulver A.E., Rivkin P., Rao V.A., Díaz-Asper C.M., Dickerson F.B., Yolken R.H., Pearlson G.D. Neuropsychological functioning in bipolar disorder and schizophrenia. Biol. Psychiatry 2007, 62(2):179-186.
47. Su L., Cai Y., Wang L., Shi S. Various effects of antipsychotics on P50 sensory gating in Chinese schizophrenia patients: a meta-analysis. Psychiatr. Danub. 2012, 24:44-50.
48. Swerdlow N.R., Light G.A., Cadenhead K.S., Sprock J., Hsieh M.H., Braff D.L. Startle gating deficits in a large cohort of patients with schizophrenia: relationship to medications, symptoms, neurocognition, and level of function. Arch. Gen. Psychiatry 2006, 63:1325-1335.
49. Thaker G.K. Neurophysiological endophenotypes across bipolar and schizophrenia psychosis. Schizophr. Bull. 2008, 34:760-773.
50. Thoma R.J., Hanlon F.M., Moses S.N., Edgar J.C., Huang M., Weisend M.P., Irwin J., Sherwood A., Paulson K., Bustillo J., Adler L.E., Miller G.A., Cañive J.M. Lateralization of auditory sensory gating and neuropsychological dysfunction in schizophrenia. Am. J. Psychiatry 2003, 160:1595-1605.
51. Thoma R.J., Hanlon F.M., Sánchez N., Weisend M.P., Huang M., Jones A., Miller G.A., Cañive J.M. Auditory sensory gating deficit and cortical thickness in schizophrenia. Neurol. Clin. Neurophysiol. 2004, 21:62-66.
52. Turetsky B.I., Calkins M.E., Light G.A., Olincy A., Radant A.D., Swerdlow N.R. Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures. Schizophr. Bull. 2007, 33:69-94.
53. Turetsky B.I., Dent G., Jaeger J., Zukin S.R. P50 amplitude reduction: a nicotinic receptor-mediated deficit in first degree relatives of schizophrenia patients. Psychopharmacology 2012, 221:39-52.
54. Venables P. Input dysfunction in schizophrenia. Progress in Experimental Personality Research 1964, 1-47. Academic Press, New York NY. B.A. Maher (Ed.).
55. Woodward N.D., Purdon S.E., Meltzer H.Y., Zald D.H. A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia. Int. J. Neuropsychopharmacol. 2005, 8:457-472.